Page last updated: 2024-09-03
c 1311 and Neutropenia
c 1311 has been researched along with Neutropenia in 1 studies
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Bourbouloux, E; Campone, M; Capizzi, R; Drouin, M; Fumoleau, P; Grieshaber, C; Isambert, N; Loadman, P; Major, A; Yin, W | 1 |
Trials
1 trial(s) available for c 1311 and Neutropenia
| Article | Year |
|---|---|
Evaluation of the safety of C-1311 (SYMADEX) administered in a phase 1 dose escalation trial as a weekly infusion for 3 consecutive weeks in patients with advanced solid tumours.
Topics: Administration, Oral; Adult; Aged; Aminoacridines; Antineoplastic Agents; Biological Availability; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasms; Neutropenia; Treatment Outcome | 2010 |